Cargando…
Can the Nasal Cavity Help Tackle COVID-19?
Despite the progress made in the fight against the COVID-19 pandemic, it still poses dramatic challenges for scientists around the world. Various approaches are applied, including repurposed medications and alternative routes for administration. Several vaccines have been approved, and many more are...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537957/ https://www.ncbi.nlm.nih.gov/pubmed/34683904 http://dx.doi.org/10.3390/pharmaceutics13101612 |
_version_ | 1784588392557707264 |
---|---|
author | Pilicheva, Bissera Boyuklieva, Radka |
author_facet | Pilicheva, Bissera Boyuklieva, Radka |
author_sort | Pilicheva, Bissera |
collection | PubMed |
description | Despite the progress made in the fight against the COVID-19 pandemic, it still poses dramatic challenges for scientists around the world. Various approaches are applied, including repurposed medications and alternative routes for administration. Several vaccines have been approved, and many more are under clinical and preclinical investigation. This review aims to systemize the available information and to outline the key therapeutic strategies for COVID-19, based on the nasal route of administration. |
format | Online Article Text |
id | pubmed-8537957 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85379572021-10-24 Can the Nasal Cavity Help Tackle COVID-19? Pilicheva, Bissera Boyuklieva, Radka Pharmaceutics Review Despite the progress made in the fight against the COVID-19 pandemic, it still poses dramatic challenges for scientists around the world. Various approaches are applied, including repurposed medications and alternative routes for administration. Several vaccines have been approved, and many more are under clinical and preclinical investigation. This review aims to systemize the available information and to outline the key therapeutic strategies for COVID-19, based on the nasal route of administration. MDPI 2021-10-03 /pmc/articles/PMC8537957/ /pubmed/34683904 http://dx.doi.org/10.3390/pharmaceutics13101612 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Pilicheva, Bissera Boyuklieva, Radka Can the Nasal Cavity Help Tackle COVID-19? |
title | Can the Nasal Cavity Help Tackle COVID-19? |
title_full | Can the Nasal Cavity Help Tackle COVID-19? |
title_fullStr | Can the Nasal Cavity Help Tackle COVID-19? |
title_full_unstemmed | Can the Nasal Cavity Help Tackle COVID-19? |
title_short | Can the Nasal Cavity Help Tackle COVID-19? |
title_sort | can the nasal cavity help tackle covid-19? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537957/ https://www.ncbi.nlm.nih.gov/pubmed/34683904 http://dx.doi.org/10.3390/pharmaceutics13101612 |
work_keys_str_mv | AT pilichevabissera canthenasalcavityhelptacklecovid19 AT boyuklievaradka canthenasalcavityhelptacklecovid19 |